Updates on the latest news, research and collaborations emerging from IBRI.
News & Publications
Keep up with our progress
Newsroom
Press Release
11/17/2025
Indiana Biosciences Research Institute Announces Research Partnership with Eli Lilly and Company
Read more
Press Release
10/29/2025
Indiana Biosciences Research Institute Keeps MBX Biosciences Growing in Indiana
Read more
Press Release
10/14/2025
Indiana Biosciences Research Institute Welcomes Dr. Ari Landon as Chief Scientific Business Development Officer
Read more
News Article
04/05/2024
IU Indianapolis eager to achieve top-tier research status
Read more
News Article
03/15/2024
Pervasive AI
Read more
News Article
03/15/2024
Moving AI from the imagination to the real world
Read more
Press Release
11/17/2025
Indiana Biosciences Research Institute Announces Research Partnership with Eli Lilly and Company
Read more
Press Release
10/29/2025
Indiana Biosciences Research Institute Keeps MBX Biosciences Growing in Indiana
Read more
Press Release
10/14/2025
Indiana Biosciences Research Institute Welcomes Dr. Ari Landon as Chief Scientific Business Development Officer
Read more
Press Release
01/11/2024
IBRI and Roche Diagnostics Announce Winner of the Inaugural Quantum Leap Award
Read more
Press Release
08/22/2023
Indiana Biosciences Research Institute and BiomEdit Announce Integrated Drug Discovery Collaboration
Read more
Press Release
06/21/2023
Indiana Biosciences Research Institute and Roche Diagnostics Announce Launch of Quantum Leap Award
Read more
Annual Reports
Publications & Presentations
02/01/2024
Discovery of lirafugratinib (RLY-4008), a highly selective irreversible small-molecule inhibitor of FGFR2
Read more
01/11/2024
RIPK3 promotes islet amyloid-induced ß-cell loss and glucose intolerance in a humanized mouse model of type 2 diabetes
Read more
01/03/2024
Discovery and clinical proof-of-concept of RLY-2608, a first-in-class mutant-selective allosteric P13Ka inhibitor that decouples antitumor activity from hyperinsulinemia
Read more
10/05/2023
Which small molecule? Selecting chemical probes for use in cancer research and target validation
Read more
07/05/2023
Expanding Chemical Probe Space: Quality Criteria for Covalent and Degrader Probes
Read more
11/22/2022
Therapeutic strategies targeting pancreatic islet beta-cell proliferation, regeneration and replacement
Read more
Keep me updated
Sign up for our newsletter to stay updated on IBRI’s progress.
"*" indicates required fields